At EndoSlim Clinic, we focus on non-surgical treatments
Due to the wordwide shortage of GLP-1 receptor agonists such as Wegovy and Zepbound, the FDA has issued an emergency decree allowing for compounding pharmacies to pick up the slack
Less common side effects Beyond the gastrointestinal basics, tirzepatide can cause other effects that catch some members off guard: Fatigue is reported by a meaningful subset of users, particularly in the early weeks
We talked about APOE4 previously, but there's a variety of genes that people have
The Turning Point: Ozempic (2017) Things changed significantly when Ozempic (semaglutide) was approved in 2017
Instead of asking 'why not stack them,' the question becomes 'what specific outcome justifies adding a second compound with incomplete human safety data?' For research exploring maximal metabolic intervention where single-agent tirzepatide has plateaued, the stack may be defensible